FDA Defends Plan to Regulate Lab-Developed Tests
September 10, 2014
(Science) – A move by the U.S. Food and Drug Administration (FDA) to regulate diagnostic tests developed in thousands of laboratories is picking up steam—and drawing fire. The agency recently notified Congress that it plans to regulate some of these so-called laboratory developed tests (LDTs)—which, unlike tests marketed by diagnostic manufacturers, don’t currently require FDA approval. FDA has not yet released a draft guidance on the matter, but at a hearing yesterday, members of the U.S. House of Representatives Energy & Commerce Committee’s health subcommittee raised questions about the agency’s authority to regulate these tests, its motivation for doing so, and the potential impact of such regulations on the diagnostic industry.